JLE

Innovations & Thérapeutiques en Oncologie

MENU

Cessation of tyrosine kinase inhibitors for chronic myeloid leukaemia: from remission without treatment to functional cure Volume 8, issue 6, November-December 2022

Export citation

Citation of this article, in the « Vancouver » format:

François-Xavier Mahon. Cessation of tyrosine kinase inhibitors for chronic myeloid leukaemia: from remission without treatment to functional cure. Innovations & Thérapeutiques en Oncologie. 2022;8(6):299-306. doi:10.1684/ito.2022.0354

Download (RIS) Add to my bibliography

The citations in my bibliography.